Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: Esophageal cancer represents a substantial global health challenge. Given their diverse socio-economic profiles and large populations, the BRICS countries are pivotal in elucidating the burden of this disease. Nonetheless, limited research has systematically examined the trends of esophageal cancer within these nations.

Method: This research utilized data from the GBD database, encompassing ASIR, ASPR, ASMR, ASDR, and 95% UI. The EAPC was employed to assess trends, while the BAPC model was used to project future trends. Four risk factors were examined, and health inequalities were evaluated using SII and CI.

Result: In 2021, China reported the highest rates across all metrics among BRICS countries, whereas Egypt exhibited the lowest rates in most cases. Smoking was identified as the predominant factor contributing to esophageal cancer mortality and DALYs in the majority of countries. Ethiopia demonstrated the highest proportion of cases attributable to a diet low in vegetables, India to tobacco chewing, and Russia to alcohol consumption. Health inequalities between countries were observed to be gradually narrowing. Projections indicate that from 2021 to 2030, Egypt, Iran, and South Africa will experience declines across all rates. Brazil, Russia, India, and the UAE are expected to see reductions in ASIR, ASPR, and ASDR but increases in ASMR. Conversely, China's ASIR, ASPR, and ASMR are projected to rise, except for ASDR. In Saudi Arabia, ASPR and ASMR are anticipated to increase, while ASIR and ASDR will decrease. Ethiopia is expected to witness increases in most rates.

Conclusion: This study examined the burden of esophageal cancer in BRICS countries. Recognizing the disparities across multiple dimensions can aid these nations in formulating more effective public health strategies and optimizing resource allocation, both of which are essential for the prevention and control of the disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12402698PMC
http://dx.doi.org/10.3389/fonc.2025.1616702DOI Listing

Publication Analysis

Top Keywords

esophageal cancer
20
brics countries
12
asir aspr
12
aspr asmr
12
health inequalities
8
esophageal
5
cancer
5
countries
5
epidemiological trends
4
trends projections
4

Similar Publications

Background: The optimal number of examined lymph nodes (ELN) for accurate staging and prognosis for esophageal cancer patients receiving neoadjuvant therapy remains controversial. This study aimed to evaluate the impact of ELN count on pathologic staging and survival outcomes and to develop a predictive model for lymph node positivity in this patient population.

Methods: Data were extracted from the Surveillance, Epidemiology, and End Results (SEER) database and a multicenter cohort.

View Article and Find Full Text PDF

Introduction: There are no reports of patients undergoing McKeown esophagectomy for esophageal cancer after undergoing pancreaticoduodenectomy for pancreatic cancer. We report the case of a patient who underwent subtotal esophagectomy and colon reconstruction after pancreaticoduodenectomy using the mesenteric approach.

Case Presentation: A 71-year-old male was diagnosed with advanced esophageal cancer.

View Article and Find Full Text PDF

Esophageal-respiratory fistulae are abnormal communications between the esophagus and the respiratory tract, most commonly appearing as tracheoesophageal or bronchoesophageal fistulas. Esophago-pulmonary fistulas represent a rare subtype, typically associated with malignancy, and may lead to severe complications such as lung abscesses. We report a case of a 58-year-old male patient who presented with a two-week history of fever, foul-smelling mucoid sputum, dyspnea, dysphagia, and weight loss.

View Article and Find Full Text PDF

Novel role of MKRN2 in regulating tumor growth through host microenvironment and macrophage M1 to M2 switch.

Cancer Lett

September 2025

State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Department of Radiology, Department of Clinical Research and Translational Medicine, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou,

The tumor microenvironment (TME) plays a pivotal role in cancer progression, though the molecular regulators governing its immunosuppressive properties remain incompletely characterized. In this study, we identify Makorin-2 (MKRN2) as a novel modulator of TME remodeling through integrated analyses of genetically engineered mouse models and human clinical data. Utilizing MKRN2 knockout mice, we observed significantly accelerated tumor growth compared to wild-type control, which was associated with profound alterations in immune cell composition, especially M2 macrophages.

View Article and Find Full Text PDF